头颈癌治疗后的视力变化
该横断面研究通过电子邮件向485例头颈癌患者发送美国国立眼科研究所视功能问卷(NEI-VFQ)和眼部症状量表,126例回复(26%),114例完成调查。视力变化组NEI-VFQ评分显著低于无视力变化组(p < 0.001),所有眼部症状在两组间均有显著差异(p < 0.05)。作者认为头颈癌治疗后的视力筛查是有必要的。
要点
- 头颈癌治疗后视力变化组NEI-VFQ评分显著低于无视力变化组(p < 0.001)。
- 所有眼部症状在视力变化组与无视力变化组间均有显著差异(p < 0.05)。
- 作者认为头颈癌治疗后的视力筛查是有必要的。
核心结论
- 这些发现及文献的稀缺提示头颈癌治疗后的视力筛查是有必要的。
研究设计与样本
- 横断面设计,向485例头颈癌患者通过电子邮件发送美国国立眼科研究所视功能问卷(NEI-VFQ)和眼部症状量表,126例回复(26%),其中114例完成调查。
主要发现
- 视力变化组NEI-VFQ评分显著低于无视力变化组(p < 0.001)。
- 所有眼部症状在视力变化组与无视力变化组之间均有显著差异(p < 0.05)。
临床怎么用
- 作者认为头颈癌治疗后的视力筛查是有必要的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Literature about ocular toxicity after head and neck cancer (HNC) treatment is scarce. This study aimed to describe visual function and ocular symptoms among HNC patients. METHODS: The study used a cross-sectional design. Two surveys, The National Eye Institute Visual Functioning Questionnaire (NEI-VFQ) and an Ocular Symptom Scale, were sent to participants via e-mail. Descriptive statistics were used to describe the sample in the vision change and non-vision change groups. Chi-square and t-tests were used to compare groups. RESULTS: Of the 485 HNC patients emailed, 126 responded to the survey (26%). Of those, 114 completed the surveys. The scores of NEI-VFQ were significantly lower in the vision change group than in the non-vision change group (p < 0.001). Similarly, all ocular symptoms were significantly different between the two groups (p < 0.05). CONCLUSIONS: These findings and a scarcity of literature suggest that vision screening after HNC treatment is warranted.
引用
- Wang HL, Heskett M, Li P, et al. Vision Changes After Head and Neck Cancer Treatment. Head Neck. 2025. PMID: 40087146. doi:10.1002/hed.28133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。